Merck’s Enlicitide Decanoate Achieves Key Breakthrough in Cholesterol Trials
Merck’s experimental drug Enlicitide Decanoate has achieved significant success in two late-stage clinical trials, the company announced on June 9, 2025. The trials demonstrated the drug’s ability to substantially lower LDL-C levels, commonly referred to as bad cholesterol, in patients with hyperlipidemia, a condition involving high-fat buildup in blood vessels.
The drug was tested in individuals with a history of, or high risk for, heart disease. Results confirmed meaningful reductions in LDL-C levels, making Enlicitide Decanoate a promising candidate for managing cholesterol-related health risks.
Hyperlipidemia is a key driver of cardiovascular disease globally, and Merck’s breakthrough has the potential to transform treatment strategies for millions of at-risk patients.
You May Interested In
SS-31 Cosmetic peptides, discounted price improving cognitive impairment factory supply
$8E+1/UNIT FOB
2026-09-09
Trade Alert
Delivering the latest product trends and industry news straight to your inbox.
(We'll never share your email address with a third-party.)
Related News
-
$12 Billion Merger! A New North American Chemical Giant Is About to Be Born
-
Brazil’s SISPA Platform Signals a New Phase in Pesticide Registration
-
Huntsman Partners with Wobatek to Expand TPU Distribution
-
Eurofragance Launches Proprietary Fragrance Ingredient Olivante
-
Mitsubishi Chemical to Halt Production of Key Epoxy Resin Grades by 2027
-
Europe’s Chemical Industry Sounds the “Shutdown Alarm”: It’s Not Just a Few Plants at Risk—The Entire Industrial Chain Is Shaking
-
L Catterton to Acquire Minority Stake in Perfume Company EX NIHILO
-
Türkiye Advances $3 Billion Petrochemical Cluster Targeting 17% of Domestic Polypropylene Demand
-
Dow Swings from an $801 Million Loss to an $802 Million Profit as Hormuz Disruption Lifts Polyethylene Prices
-
Argentina to Build Latin America’s Largest Urea Plant Under €1.3 Billion Contract
Recommend Reading
-
![BASF Launches Global Expansion Plan for Aroma Ingredients]()
BASF Launches Global Expansion Plan for Aroma Ingredients
-
![BASF Launches Global Expansion Plan for Aroma Ingredients]()
BASF Launches Global Expansion Plan for Aroma Ingredients
-
![BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync]()
BASF's Intensified Moves from May to June: Plant Closures, Divestitures, and Transformation in Sync
-
![From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse]()
From Desert Sands to Dining Tables: Arab Food & Beverage Sector Emerges as Investment Powerhouse
-
![Henkel's Acquisition of Stahl Enters Regulatory Countdown: Will the €2.1 Billion Deal Go Through?]()
Henkel's Acquisition of Stahl Enters Regulatory Countdown: Will the €2.1 Billion Deal Go Through?
-
![November Natural Rubber Market Prices Fluctuate and Rise Slightly in China]()
November Natural Rubber Market Prices Fluctuate and Rise Slightly in China
-
![Demand Falls Short of Expectations, Shandong Cyclohexanone Market Trending Downward]()
Demand Falls Short of Expectations, Shandong Cyclohexanone Market Trending Downward
-
![Negative Factors Weighing Down, Palm Oil Prices Weak and Declining]()
Negative Factors Weighing Down, Palm Oil Prices Weak and Declining
-
![In November, PVC Continues to Decline, Market Shows Signs of Stabilization]()
In November, PVC Continues to Decline, Market Shows Signs of Stabilization
-
![September dichloromethane market continues to bottom out]()
September dichloromethane market continues to bottom out
